Cole Douglas G.

CIK 000148637310 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001486373

Recent Transactions

50 trades

Award
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2025-06-17$4.79/sh+25,000→ 25,000 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Options (Right to buy)
2024-06-26$5.52/sh+16,000→ 16,000 total
Award
Sana Biotechnology, Inc.$SANA
Stock Option (Right to Buy)
2024-06-06+65,000→ 65,000 total
Award
Sana Biotechnology, Inc.$SANA
Stock Option (Right to Buy)
2024-06-06+54,278→ 54,278 total
Disposition to Issuer
Sigilon Therapeutics, Inc.
Stock Option (Right to Buy)
2023-08-11$6.64/sh−683→ 0 total
Disposition to Issuer
Sigilon Therapeutics, Inc.
Stock Option (Right to Buy)
2023-08-11$5.00/sh−683→ 0 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2023-06-21+16,000→ 16,000 total
Award
Sana Biotechnology, Inc.$SANA
Stock Option (Right to Buy)
2023-06-08+65,000→ 65,000 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-06-01+12,649→ 12,649 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2023-06-01+4,216→ 26,564 total
Award
Sigilon Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-19+8,888→ 8,888 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Options (Right to buy)
2022-06-21+16,000→ 16,000 total
Award
Sana Biotechnology, Inc.$SANA
Stock Option (Right to Buy)
2022-06-06+65,000→ 65,000 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2022-06-02+17,959→ 17,959 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2022-06-02+5,986→ 22,348 total
Award
Sigilon Therapeutics, Inc.
Stock Option (Right to Buy)
2022-05-26+8,888→ 8,888 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2021-07-13+12,530→ 12,530 total
Award
Sigilon Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-24$9.97/sh+8,888→ 8,888 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2021-06-02+6,222→ 6,222 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2021-06-02+2,074→ 5,327 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Restricted Stock Units
2021-06-01−3,253→ 0 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2021-06-01+3,253→ 3,253 total
Award
Sana Biotechnology, Inc.$SANA
Stock Option (Right to Buy)
2021-02-03+14,000→ 14,000 total
Award
Sana Biotechnology, Inc.$SANA
Stock Option (Right to Buy)
2021-02-03−23,591→ 23,591 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2020-06-03+15,183→ 15,183 total
Award
Denali Therapeutics Inc.$DNLI
Restricted Stock Units
2020-06-03+3,253→ 3,253 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2019-05-30+27,245→ 27,245 total
Award
Quanterix Corp$QTRX
Stock Option (Right to Buy)
2019-01-02+7,900→ 7,900 total
Award
Quanterix Corp$QTRX
Common Stock
2019-01-02+2,270→ 4,540 total
Award
Quanterix Corp$QTRX
Common Stock
2018-08-07+2,270→ 2,270 total
Award
Quanterix Corp$QTRX
Stock Option (Right to Buy)
2018-08-07+7,900→ 7,900 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2018-06-13+27,830→ 27,830 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2017-12-07+47,165→ 47,165 total
Other
Editas Medicine, Inc.$EDIT
Common Stock
2017-08-17+1,686→ 3,171 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2017-06-15+11,538→ 11,538 total
Other
Editas Medicine, Inc.$EDIT
Common Stock
2016-08-11+1,485→ 1,485 total
Other
AGIOS PHARMACEUTICALS, INC.$AGIO
Common Stock
2016-08-10+917→ 2,778 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2016-06-21+8,000→ 31,125 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock Option (right to buy)
2015-06-23+10,625→ 23,125 total
Award
Receptos, Inc.
Stock Option (right to buy)
2013-07-17+18,800→ 18,800 total
Award
TETRAPHASE PHARMACEUTICALS INC
Non-qualified Stock Option (right to buy)
2013-03-25+20,000→ 20,000 total
Award
TETRAPHASE PHARMACEUTICALS INC
Non-qualified Stock Option (right to buy)
2013-03-25+20,000→ 20,000 total
Sale
AVEO PHARMACEUTICALS, INC.
Common Stock
2011-05-16$17.98/sh−2,992→ 23,909 total
Sale
AVEO PHARMACEUTICALS, INC.
Common Stock
2011-05-16$17.98/sh−49,500→ 395,565 total
Sale
AVEO PHARMACEUTICALS, INC.
Common Stock
2011-05-13$17.75/sh−76,750→ 445,065 total
Sale
AVEO PHARMACEUTICALS, INC.
Common Stock
2011-05-13$17.75/sh−4,639→ 26,901 total
Sale
AVEO PHARMACEUTICALS, INC.
Common Stock
2011-05-12$17.30/sh−919→ 31,540 total
Sale
AVEO PHARMACEUTICALS, INC.
Common Stock
2011-05-12$17.30/sh−15,200→ 521,815 total
Conversion
AVEO PHARMACEUTICALS, INC.
Common Stock
2011-03-17+725,384→ 725,384 total
Conversion
AVEO PHARMACEUTICALS, INC.
Common Stock
2011-03-17+94,531→ 819,915 total

Companies

Recent Filings

Address

C/O AVEO PHARMACEUTICALS, INC. 75 SIDNEY STREET

CAMBRIDGE, MA, 02139

View on SEC.gov